Get the Stockscreener App
54.53
0.33%
0.18
Disc Medicine Inc stock is traded at $54.53, with a volume of 425.21K.
It is up +0.33% in the last 24 hours and down -9.90% over the past month.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
See More
Previous Close:
$54.35
Open:
$55.09
24h Volume:
425.21K
Relative Volume:
1.33
Market Cap:
$1.87B
Revenue:
-
Net Income/Loss:
$-91.00M
P/E Ratio:
-14.86
EPS:
-3.67
Net Cash Flow:
$-74.38M
1W Performance:
+0.79%
1M Performance:
-9.90%
6M Performance:
+10.59%
1Y Performance:
-15.93%
1-Day Range:
$54.04
$55.80
1-Week Range:
$52.21
$55.89
52-Week Range:
$25.60
$77.60
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
(617) 674-9274
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
54.53 | 1.87B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-04-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-23-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-01-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jun-07-23 | Initiated | H.C. Wainwright | Buy |
| May-17-23 | Initiated | Raymond James | Outperform |
| Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-21-23 | Initiated | Stifel | Buy |
| Apr-20-23 | Initiated | Morgan Stanley | Overweight |
| Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
Disc medicine officer sells shares worth $171,217 By Investing.com - Investing.com Nigeria
Disc Medicine’s chief legal officer Rahul Khara sells $63,367 in stock - Investing.com Nigeria
Disc Medicine's chief legal officer Rahul Khara sells $63,367 in stock - Investing.com Australia
Disc medicine COO Yu sells $87,873 in stock By Investing.com - Investing.com South Africa
Disc Medicine CEO John Quisel sells $304,228 in stock By Investing.com - Investing.com Nigeria
Disc medicine officer sells shares worth $171,217 - Investing.com India
Disc medicine COO Yu sells $87,873 in stock - Investing.com
Disc Medicine's chief medical officer sells shares worth $89,402 - Investing.com
Disc Medicine CEO John Quisel sells $304,228 in stock - Investing.com India
Disc Medicine Executives Sell Shares to Cover Tax Obligations - TradingView
Disc Medicine CEO Sells Shares to Cover Tax Obligations - TradingView
Short Interest in Disc Medicine, Inc. (NASDAQ:IRON) Increases By 6.4% - Defense World
Disc Medicine's SWOT analysis: rare blood disorder stock poised for growth - Investing.com Nigeria
How To Trade (IRON) - Stock Traders Daily
Disc Medicine announces pricing of $225.5M upsized public offering - MSN
Bleakley Financial Group LLC Invests $486,000 in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
FY2025 EPS Estimates for Disc Medicine Increased by Analyst - MarketBeat
Disc Medicine, Inc. (IRON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq
Disc Medicine FY2025 EPS Forecast Lifted by Leerink Partnrs - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Insider Rahul Khara Sells 7,500 Shares - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Short Interest Update - MarketBeat
Where are the Opportunities in (IRON) - Stock Traders Daily
Disc Medicine Inc (IRON) can make a big difference with a little luck - SETE News
Short Interest in Disc Medicine, Inc. (NASDAQ:IRON) Increases By 6.6% - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by SG Americas Securities LLC - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Receives $88.90 Consensus PT from Analysts - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
WilmerHale Advises Underwriters in Upsized $259.3 Million Follow-on Public Offering of Disc Medicine - WilmerHale
JPMorgan Chase & Co. Purchases 2,257 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
JPMorgan Chase & Co. Increases Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - ETF Daily News
Stifel Nicolaus Increases Disc Medicine (NASDAQ:IRON) Price Target to $94.00 - MarketBeat
Stifel raises Disc Medicine stock target to $94, maintains Buy By Investing.com - Investing.com Canada
Stifel raises Disc Medicine stock target to $94, maintains Buy - Investing.com India
Disc Medicine (NASDAQ:IRON) Sees Large Volume Increase After Analyst Upgrade - MarketBeat
Disc Medicine’s (IRON) Outperform Rating Reiterated at Wedbush - Defense World
Disc Medicine (NASDAQ:IRON) Sees Unusually-High Trading Volume on Analyst Upgrade - Defense World
FY2026 Earnings Estimate for Disc Medicine Issued By Wedbush - MarketBeat
Disc raises $225.5m as it eyes approval of rare skin disorder drug - Yahoo Finance
Cantor Fitzgerald Comments on Disc Medicine FY2025 Earnings - Defense World
Disc Medicine Raises $225.5M in Upsized Public Offering to Advance Bitopertin Development - StockTitan
Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Disc Medicine (NASDAQ:IRON) Shares Gap DownHere's Why - MarketBeat
Scotiabank Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
FY2028 Earnings Estimate for Disc Medicine Issued By Wedbush - MarketBeat
Cantor Fitzgerald Estimates Disc Medicine FY2025 Earnings - MarketBeat
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Disc Medicine Inc Stock (IRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Disc Medicine Inc Stock (IRON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Khara Rahul | Chief Legal Officer |
Feb 18 '25 |
Sale |
54.58 |
1,161 |
63,367 |
37,583 |
| Savage William Jacob | Chief Medical Officer |
Feb 18 '25 |
Sale |
54.58 |
1,638 |
89,402 |
68,498 |
| Yu Jonathan Yen-Wen | Chief Operating Officer |
Feb 18 '25 |
Sale |
54.58 |
1,610 |
87,874 |
40,555 |
| Franchi Jean M. | Chief Financial Officer |
Feb 18 '25 |
Sale |
54.58 |
3,136 |
171,163 |
69,530 |
| Quisel John D | Chief Executive Officer |
Feb 18 '25 |
Sale |
54.58 |
5,574 |
304,229 |
154,828 |
| Savage William Jacob | Chief Medical Officer |
Feb 03 '25 |
Option Exercise |
2.65 |
5,731 |
15,187 |
46,136 |
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):